Share on :

Asset Summary

Weekly Performance Report for BIO ETF: Week 52, 2024

Summary: The Weekly started with BIO ETF opening at $325.44 and closing at $330.53. The ETF showed resilience throughout the Weekly, with the highest price observed at $330.53 and the lowest at $323.56. The underlying asset had a trading range of $6.97 Overall, it was a positive trading Weekly for BIO ETF, reflecting investor optimism and market activity.

Change in Closing Price: There was a net increase of $5.09 or 1.56% in the closing price from the opening to the closing price over the Weekly.

Volume Analysis: Trading volume for BIO ETF was 143,532 units during Week 52, indicating active market participation and investor interest.

Opening Price: The Weekly started at $325.44.

Highest Price: The highest price observed during the Weekly was $330.53.

Lowest Price: The lowest price observed during the Weekly was $323.56.

Closing Price: The Weekly ended at $330.53.

Asset Performance Metrics and Risk Characteristics:

Understanding asset performance is crucial for evaluating investment quality and making informed decisions. Metrics like trailing return and drawdown provide insights into how an asset has performed over time, its volatility, and the efficiency of its returns relative to risk. Performance indicators help assess the stability, risk, and reward of an investment, allowing investors and portfolio managers to make comparisons and strategize accordingly.

Asset Technical Analysis

Technical analysis involves evaluating an asset's price and volume data to forecast future movements and make informed trading decisions. By using various technical indicators and chart patterns, investors can gain insights into market trends, price momentum, and potential turning points. This section delves into essential technical metrics, including moving averages, pivot points, and other indicators that provide a snapshot of an asset's current technical stance. Analyzing these indicators helps investors identify entry and exit points, assess market sentiment, and refine their trading strategies. Explore the following technical analysis data to understand the asset's performance dynamics and make better-informed decisions.

Moving Averages

Moving Averages are commonly used to smooth out price data and identify trends over a specific period. Here’s a summary of the latest moving averages for various periods:

  • SMA (Simple Moving Average): Reflects the average price over a specific number of periods.
  • EMA (Exponential Moving Average): Gives more weight to recent prices, making it more responsive to new information.
  • WMA (Weighted Moving Average): Assigns a weight to each price, emphasizing more recent prices.
  • WEMA (Weighted Exponential Moving Average): Combines elements of both WMA and EMA for a more responsive moving average.

Optimize Your BIO Trading Now

Discover unparalleled trading insights with RankMyTrade Platform. Our automated system offers advanced analysis and technical indicators for BIO, aimed at optimizing your trading decisions. Transform your trading strategy now and get ahead in the market now!

Boost Performance Now

Frequently Asked Questions

Yes, Biogen is involved in corporate social responsibility initiatives, focusing on access to medicines and supporting communities.

You can check Biogen’s stock performance on financial news websites and stock market platforms.

Biogen’s financial reports are available on their investor relations website, including quarterly and annual reports.

Yes, Biogen offers internships and various career opportunities in the biotechnology and pharmaceutical sectors.

You can contact Biogen investor relations through their official website for inquiries related to the company’s financial performance.

Biogen is committed to sustainability and aims to reduce its environmental impact through various initiatives, including reducing greenhouse gas emissions.

Biogen plays a significant role in the Alzheimer’s disease community by developing potential treatments and supporting research efforts.

Biogen collaborates with various academic and industry partners to advance its research and development efforts.

Biogen offers a range of therapies, including those for multiple sclerosis, Alzheimer’s disease, and other neurodegenerative conditions.

Biogen is headquartered in Cambridge, Massachusetts, USA.

Unleash Your BIO Trading Now

Elevate your trading strategy with RankMyTrade.com’s sophisticated tools for BIO. Our system integrates cutting-edge technology and expert analysis to support your investment goals. Transform your trading strategy now and explore the benefits of advanced trading now!

Disclaimers

The information displayed on this site is sourced from third-party providers and is believed to be reliable. RankMyTrade (RMT) has not independently verified this data and does not guarantee its accuracy. The information and calculations provided by RankMyTrade are for educational and informational purposes only and should not be construed as financial or investment advice.

With any investment, your capital is at risk. The value of your portfolio go down as well as up. Past performance is no guarantee of future results. By using this website, you accept our Terms of Service, Privacy Policy, and Payment Agreement.

Market data is provided in near real-time when available, but we do not guarantee its accuracy or timeliness.

Securities products are: Not FDIC insured · Not bank guaranteed · May lose value

Trademarks and logos are the property of their respective owners and do not represent endorsements of any kind. Unless otherwise noted, RankMyTrade and its affiliates are not partners, affiliates, or licensees of these companies.

Supported Assets & ETFs